MIMEDX Announces First Quarter 2024 Operating and Financial

30.04.2024 - Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management to Host Conference Call Today, April 30, 2024, ...

Related Keywords

Josephh Capper , Matt Notarianni , Regenity Biosciences , International Investors , Company Board Of Directors , Exchange Commission , Mimedx Group Inc , Bio Inc , Nasdaq , Host Conference Call Today , Medx Group , Financial Highlights , Executive Officer , Months Ended March , Regenerative Medicine , Annual Report , Risk Factors , Consolidated Statements , Free Cash Flow , Adjusted Net Income , Adjusted Earnings Per Share , Hayfin Loan , Tax Adjustment , Net Income , Earnings Per Share , Cash Flow , Mimedx Group Chart , Imedx Group Kurs , Imedx Group Aktie ,